Metastatic Castration-resistant Prostate Neoplasms Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Neoplasms
Janssen Research & Development, LLC277 enrolled15 locationsNCT05818683
Recruiting
Phase 3
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Metastatic Castration-resistant Prostate Neoplasms
Janssen Research & Development, LLC663 enrolled81 locationsNCT07164443